MEDICARE Rx BENEFIT WOULD ADD $16 BIL. IN SALES FOR BRANDNAME MANUFACTURERS IN FIRST FIVE YEARS, HHS PROJECTS; NET GAIN FOR U.S. DRUG FIRMS ESTIMATED AT $2.4 BIL.
Executive Summary
President Clinton's proposed Medicare drug benefit would add $ 16 bil. in revenues net of rebates to brandname manufacturers in the first five years, HHS Assistant Secretary for Health Philip Lee, MD, told a Feb. 8 House Energy & Commerce/Health Subcommittee hearing.